Fisher Asset Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $195M | Sell |
2,976,691
-166,258
| -5% | -$10.9M | 0.08% | 132 |
|
|
2025
Q1 | $222M | Sell |
3,142,949
-83,745
| -3% | -$5.91M | 0.1% | 121 |
|
|
2024
Q4 | $212M | Sell |
3,226,694
-125,550
| -4% | -$8.25M | 0.08% | 122 |
|
|
2024
Q3 | $237M | Sell |
3,352,244
-88,758
| -3% | -$6.27M | 0.1% | 121 |
|
|
2024
Q2 | $228M | Sell |
3,441,002
-94,857
| -3% | -$6.29M | 0.1% | 119 |
|
|
2024
Q1 | $240M | Buy |
3,535,859
+2,328,846
| +193% | +$158M | 0.11% | 118 |
|
|
2023
Q4 | $224M | Buy |
1,207,013
+1,185,696
| +5,562% | +$220M | 0.12% | 124 |
|
|
2023
Q3 | $3.77M | Sell |
21,317
-20,290
| -49% | -$3.59M | ﹤0.01% | 551 |
|
|
2023
Q2 | $7.45M | Buy |
41,607
+3,031
| +8% | +$543K | ﹤0.01% | 488 |
|
|
2023
Q1 | $6.76M | Sell |
38,576
-149
| -0.4% | -$26.1K | ﹤0.01% | 502 |
|
|
2022
Q4 | $7.21M | Buy |
38,725
+16,875
| +77% | +$3.14M | ﹤0.01% | 497 |
|
|
2022
Q3 | $3.71M | Buy |
21,850
+13,434
| +160% | +$2.28M | ﹤0.01% | 492 |
|
|
2022
Q2 | $1.61M | Sell |
8,416
-290
| -3% | -$55.6K | ﹤0.01% | 561 |
|
|
2022
Q1 | $1.69M | Sell |
8,706
-4,685
| -35% | -$910K | ﹤0.01% | 574 |
|
|
2021
Q4 | $2.67M | Buy |
13,391
+5,645
| +73% | +$1.13M | ﹤0.01% | 527 |
|
|
2021
Q3 | $1.42M | Buy |
7,746
+465
| +6% | +$85.2K | ﹤0.01% | 565 |
|
|
2021
Q2 | $1.35M | Sell |
7,281
-1,455
| -17% | -$270K | ﹤0.01% | 572 |
|
|
2021
Q1 | $1.55M | Sell |
8,736
-547
| -6% | -$97.2K | ﹤0.01% | 557 |
|
|
2020
Q4 | $1.67M | Buy |
9,283
+4,151
| +81% | +$745K | ﹤0.01% | 540 |
|
|
2020
Q3 | $839K | Sell |
5,132
-475
| -8% | -$77.7K | ﹤0.01% | 583 |
|
|
2020
Q2 | $863K | Sell |
5,607
-6,471
| -54% | -$996K | ﹤0.01% | 586 |
|
|
2020
Q1 | $1.63M | Sell |
12,078
-35,713
| -75% | -$4.8M | ﹤0.01% | 475 |
|
|
2019
Q4 | $7.65M | Buy |
47,791
+43,560
| +1,030% | +$6.98M | 0.01% | 362 |
|
|
2019
Q3 | $592K | Buy |
4,231
+1,544
| +57% | +$216K | ﹤0.01% | 663 |
|
|
2019
Q2 | $405K | Buy |
+2,687
| New | +$405K | ﹤0.01% | 696 |
|